TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Nonfarm Payrolls (September)
SCTX

Scribe Therapeutics Inc.

Healthcare · Biotechnology

18.40$ -20.1% vs. previous close Closing price · As of: Sep 30, 2026

Statements

Balance Sheet

Scribe Therapeutics Inc. (SCTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 58 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SCTX
Line item Q1 26 Q2 26
65 58
52 45
20 36
224 223
80 79
5.1 2.8
-159 -165
-175 -182
18 18

Data as of: September 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?